If you snore, wake up gasping, or feel exhausted no matter how long you sleep, you might have sleep apnea.
And GLP-1 medications may help — not just because of weight loss, but possibly in ways we're just beginning to understand.
What Is Sleep Apnea?
Sleep apnea happens when your airway closes partially or completely during sleep. You stop breathing — sometimes hundreds of times per night. Your brain wakes you up just enough to restart breathing. You don't remember it happening, but your body does.
Common symptoms:
- Loud snoring
- Waking up gasping or choking
- Daytime exhaustion
- Morning headaches
- Trouble concentrating
- Irritability
Obesity is the biggest risk factor for sleep apnea. Extra weight around the neck puts pressure on the airway, making it more likely to collapse during sleep.
What the Research Shows
Zepbound FDA Approval for Sleep Apnea (2024)
In late 2024, the FDA approved Zepbound (tirzepatide) for the treatment of moderate-to-severe obstructive sleep apnea in adults with obesity. This was a major milestone — the first medication approved for this condition.
The approval was based on two Phase 3 trials called SURMOUNT-OSA:
SURMOUNT-OSA 1:
- 469 adults with moderate-to-severe OSA and obesity
- 72 weeks of tirzepatide treatment
- 25.5% average weight loss at the highest dose (15 mg)
- Significant reduction in apnea-hypopnea index (AHI) — the number of breathing stoppages per hour
- The improvement was partly due to weight loss but also showed effects beyond weight loss alone
SURMOUNT-OSA 2:
- Similar design, confirmed the results
- People on tirzepatide had fewer breathing events per hour compared to placebo
- Many participants were able to reduce their CPAP usage
The SELECT Trial Substudy (2024)
A substudy of the large SELECT trial looked at semaglutide (Wegovy) in people with obesity and moderate-to-severe obstructive sleep apnea.
Results:
- People on semaglutide had a significant reduction in sleep apnea severity
- The improvement was directly related to the amount of weight lost
- More weight loss = greater improvement in sleep apnea
- About 33% of people on semaglutide achieved complete resolution of their sleep apnea (AHI below 5)
Other Studies
Multiple studies have found:
- Weight loss from GLP-1s reduces sleep apnea severity
- Some people are able to reduce or stop using their CPAP machine after significant weight loss
- GLP-1s may improve sleep quality independently of sleep apnea improvement
How GLP-1s Help Sleep Apnea
1. Weight Loss
This is the biggest factor. Losing weight reduces fat around the neck and throat, which opens the airway.
- Even a 10% reduction in body weight can significantly improve sleep apnea
- Greater weight loss leads to greater improvement
2. Reduced Inflammation
Sleep apnea is linked to inflammation in the upper airway. GLP-1s reduce inflammation throughout the body, which may help reduce airway swelling.
3. Better Sleep Quality
GLP-1s may improve sleep quality directly, beyond their effect on sleep apnea. Better sleep means better energy, mood, and metabolic health.
What This Means for You
If You Have Sleep Apnea
GLP-1s may be a helpful addition to your treatment plan — especially if you also have obesity or type 2 diabetes.
Zepbound (tirzepatide) is now FDA-approved for OSA. If you have moderate-to-severe obstructive sleep apnea with obesity, ask your doctor about it. It may be covered by insurance for this indication even if you don't have diabetes.
Wegovy (semaglutide) is not FDA-approved for OSA but has strong trial data showing benefit. Your doctor may prescribe it off-label for sleep apnea.
Important: Don't stop using your CPAP machine without talking to your sleep doctor. Weight loss takes time, and your airway needs support in the meantime.
If You Think You Might Have Sleep Apnea
Talk to your doctor about getting a sleep study. Sleep apnea is serious — it increases the risk of high blood pressure, heart disease, stroke, and diabetes.
If You're on GLP-1s and Notice Better Sleep
You're not imagining it. Weight loss from GLP-1s genuinely improves sleep apnea for many people.
Don't Stop Your CPAP Too Soon
Some people lose weight on GLP-1s and assume their sleep apnea is gone. They stop using their CPAP. Big mistake.
What to do instead:
- Keep using your CPAP
- After significant weight loss (10%+ of body weight), ask your sleep doctor for a follow-up sleep study
- If the study shows your sleep apnea has resolved, your doctor may clear you to stop CPAP
- Don't make this decision on your own
When to See Your Doctor
- You snore loudly and wake up gasping
- You're exhausted during the day despite sleeping enough hours
- Your partner notices you stop breathing during sleep
- You want to discuss whether GLP-1s might help your sleep apnea
- You've lost significant weight and want to re-evaluate your CPAP needs
The Bottom Line
GLP-1 medications can improve sleep apnea through weight loss and possibly other mechanisms. But they're not a replacement for CPAP therapy — at least not right away.
Your action items:
- If you suspect sleep apnea, get a sleep study
- If you have sleep apnea, keep using your CPAP even if you start losing weight
- After significant weight loss, ask for a follow-up sleep study
- Talk to your doctor about whether GLP-1s might help your sleep apnea
- Don't stop CPAP without medical clearance
Better sleep is one of the most underrated benefits of GLP-1 treatment. If you've been struggling with sleep apnea, weight loss may be the most effective thing you can do.
This article is for informational purposes only and does not replace medical advice. Always talk to your healthcare provider about sleep apnea and CPAP use. Do not stop using your CPAP machine without medical guidance.
Found this helpful? Share it with someone who snores — they might need to hear this.
